Cigna’s stock jumps 2.7% after earnings beat estimates and company raises guidance
Post Content
The company reiterated its full-year 2024 sales guidance of roughly $4 billion, which includes revenue from the expected launch of its RSV vaccine.
The company reiterated its full-year 2024 sales guidance of roughly $4 billion, which includes revenue from the expected launch of its RSV vaccine.
The 2025 Honda Pilot is one of our favorite midsize SUVs because it performs its duties so well. Pricing starts at $41,295.
A team of UBS derivatives strategists led by Maxwell Grinacoff put together a playbook for a stagflation scenario
Carvana reported record first-quarter results Wednesday that beat Wall Street's top- and bottom-line earnings expectations for the online used car retailer.
Hong Kong-listed shares of Chinese electric vehicle maker Nio Inc jumped 20% in early trading, after its vehicle deliveries more than doubled in April.
Novo Nordisk said its Wegovy injectable drug for weight loss now has more than 130,000 weekly prescriptions in North America alone after boosting supplies to...
Shell’s first-quarter adjusted earnings fell by less than expected, buoyed by strong margins from crude and oil trading, while the energy giant kicked off a...